World

Justice Department accuses two Chinese researchers of smuggling

Jun 05, 2025

New York [US], June 5: U.S. federal prosecutors have accused two Chinese nationals of smuggling a dangerous biological pathogen that had the potential to be used as an agricultural terrorism weapon into the United States for research.
The U.S. Department of Justice on Tuesday identified the pathogen as Fusarium graminearum, a fungus it said was classified in scientific literature as a potential agroterrorism weapon.
In a statement it said that the fungus causes "head blight" in some crops and is responsible for billions of dollars in economic losses globally each year.
According to an FBI criminal complaint, Zunyong Liu, 34, a researcher currently in China, brought the fungus into the United States while visiting his girlfriend, Yunqing Jian, 33, in July 2024.
He admitted to smuggling in the fungus so he could conduct research on it at a University of Michigan laboratory where his girlfriend worked, according to the complaint.
The university did not immediately respond to a request for comment.
According to the complaint, an examination of electronic communications between the two indicated that they discussed shipping biological materials and research being done in the laboratory prior to Liu's arrival.
Jian and Liu were accused in the complaint of conspiracy, smuggling goods into the United States, false statements and visa fraud.
Cheyvoryea Gibson, special agent in charge of the FBI Detroit Field Office, said the pair's actions "posed an imminent threat to public safety."
Jian was expected to appear in court in Detroit, Michigan, on Tuesday.
A judge appointed a public defender, who could not be immediately reached for comment, to represent Jian.
Source: Fijian Broadcasting Corporation

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026